Clinical Trial Update: Steroid Sparing Treatment With in Newly Diagnosed Transplant Ineligible Patients With Multiple Myeloma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update describing a steroid-sparing treatment approach for newly diagnosed transplant-ineligible patients with multiple myeloma. The st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: University of Rochester | Conditions: Multiple Myeloma | Phase 2 | Status: ACTIVE_NOT_RECRUITING